OLYS Pharma research targets innate immune pathways to treat and prevent neurogenic inflammation of the Neuro-Immuno-Cutaneo-Endocrine (NICE) system. There are different types of stress (metabolic, osmotic, chemical, traumatic, emotional, etc.) whose intensity and duration can deregulate the response capacity of the NICE system, lead to neurogenic inflammation and lead to painful chronic inflammatory pathologies.

OLYS Pharma’s approach is unprecedented. It aims simultaneously to obtain corrective physiological responses and to restore cellular homeostasis, thanks to combined effects for:

• modulate immune responses
• inhibit the pro-inflammatory process,
• improve cellular metabolism, block apoptosis pathways,
• correct neurotransmission dysfunctions,
• block the degeneration of epidermal nerves, restore their myelination and stimulate the neo-growth of axons and dendrites